No Data
No Data
While Shareholders of Hefei Meyer Optoelectronic Technology (SZSE:002690) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown
Hefei Meyer Optoelectronic Technology Inc. (002690.SZ): Medical CT related products have not yet been applied to the pet medical industry.
On January 3, Ge Long Hui reported that Hefei Meyer Optoelectronic Technology Inc. (002690.SZ) stated on the investor interaction platform that the company's Medical Computed Tomography related products have not yet been applied to the pet Medical Industry. In the future, the company will expand new technological application directions based on the actual situation of the market environment.
Hefei Meyer Optoelectronic Technology Inc.'s (SZSE:002690) Top Holders Are Insiders and They Are Likely Disappointed by the Recent 3.7% Drop
Overview of the restricted stock release (unlocking) in A-shares | December 27.
According to Zhituo Finance APP, on December 27, a total of 10 listed companies had their restricted shares released, with a total market value of approximately 1.252 billion yuan. Today's specific situation regarding the release of restricted shares is as follows: Stock Short Name Stock Code Type of Restricted Shares Number of Shares Released Visual China Group 000681 Stock-based Incentive 172,000 Nanjing Business & Tourism Corp.,Ltd. 600250 Issued A-shares for Legal Person Allocation 26,471,800 Shede Spirits 600702 Stock-based Incentive 373,400 Beijing Aerospace Changfeng 600855 Stock-based Incentive 328,900 Hefei Meyer Optoelectronic Technology Inc. 002690 Stock-based Incentive 1,367,000.
Are Robust Financials Driving The Recent Rally In Hefei Meyer Optoelectronic Technology Inc.'s (SZSE:002690) Stock?
hefei meyer optoelectronic technology inc. (002690.SZ): The proportion of export business revenue accounts for about 20% of total revenue.
On December 2, Glonghui reported that hefei meyer optoelectronic technology inc. (002690.SZ) stated on the investor interaction platform that the revenue from the company's export business accounts for about 20% of the total revenue. With the growth of export revenue in recent years, this proportion may continue to increase in the future; for specific information, please refer to the company's publicly disclosed regular reports. The company's director, Mr. Hao Xianjin, has been continuously increasing his shareholding in the company in recent years. The company will continue to focus on its main business and maintain stable development, delivering good performance to return value to investors.